HIV and Hepatitis Policy Institute

12/12/2025

Pleased to co-author this commentary in Health Affairs on proposed legislation to end Hepatitis C in the USA. Looking foward to Congress' consideration of this important proposed program to eliminate Hep C. We have the cures, but we need to make sure people can access them.

In this Forefront article, we explore some of the critical policy and economic considerations embedded in the Cure Hepatitis C Act of 2025, highlighting the choices policy makers face in converting a bill into a successful national program.

12/09/2025

The hidden costs of co-pay assistance programs: How industry practices undermine patient access to medications: https://www.bioxconomy.com/access-and-channel/hiv-advocate-carl-schmid-warns-co-pay-accumulator-programs-leave-patients-with-surprise-bills-worth-thousands

12/08/2025

Bipartisan House Group Pushes To Ban Copay Accumulators, Patient Group Separately Lobbies OMB: https://insidehealthpolicy.com/inside-drug-pricing-daily-news/bipartisan-house-group-pushes-ban-copay-accumulators-patient-group?destination=node/152392%3Futm_medium%3Didpln

12/05/2025

Kean, Colleagues Introduce Bill to Protect Patients from High Prescription Drug Costs:

(December 4, 2025) WASHINGTON, DC – Today, Representatives Tom Kean, Jr.

12/02/2025

Insurer Adds Treatments After Discrimination Complaints--Medica Improves Formularies in Iowa and Minnesota: https://bit.ly/3XyN9rQ

12/02/2025

https://finance.yahoo.com/news/emory-university-study-published-jama-164200819.html

Nearly 1 in 5 People on PrEP in the United States Receive their PrEP through MISTR MISTR offers free online PrEP, STI Testing and HIV care A new study from Emory University, published today in the Journal of the American Medical Association (JAMA), confirms that telehealth has become a cornerstone o...

11/21/2025

Don't Reverse America's Progress Against HIV:

The federal government is poised to undo years of hard-won progress in the fight against HIV-a deadly and highly infectious disease that seems to have lost its urgency due to our successes in preventi

11/19/2025

As a proud member of the All Copays Count Coalition, today we are on the Hill calling on policymakers to address harmful insurance practices that impact patients with serious and chronic conditions.Learn more by visiting: www.allcopayscount.org.

11/19/2025

At the 2025 Copay, Reimbursement, and Access Congress, the HIV and Hepatitis Policy Institute's Carl Schmid provided a policy update on copay accumulators, maximizers, and alternative funding programs: https://bit.ly/4pbVptE

11/19/2025

Advocates warn proposed cuts to HIV treatment and prevention could hurt life saving efforts:

Clinics like Metro Inclusive Health depend on a lot of the funding that comes from programs like the "Ending the HIV Epidemic Initiative."

11/18/2025

https://www.ebar.com/story/160402/

Delta Air Lines isn’t covering long-acting injectable PrEP, or the oral PrEP drug Descovy, without prior authorization, according to a prominent HIV health policy advocate.

11/16/2025

Thank you CNBC for exposing the 3rd party vendor who are making money from importing drugs from other countries.

AFPs promise to connect patients with more-affordable options for accessing specialty medications that often come at very high costs. There's a major catch.